EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders

Rebecca Fish, Céu Mateus, Hannah Maiden, Euan Lawson, Mark Limmer

Drug and Alcohol Dependence Reports · 2025-06 · 15 · 100328

DOI: 10.1016/j.dadr.2025.100328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug and Alcohol Dependence Reports, 2025-06. Verfasst von Rebecca Fish und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Health Research, Lancaster University, UK. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Long-acting injectable buprenorphine (LAIB) is a relatively novel pharmacological treatment for people with opioid dependence. Despite growing qualitative evidence, there is limited research on practitioner insights, and effectiveness of LAIB in a community setting.

Methods

Thirteen service-users (11 currently prescribed LAIB), 6 practitioners, and 4 stakeholders (public health workers) took part in semi-structured interviews (n = 23) to glean their perspectives on LAIB. They were recruited through a community drug treatment service in the NW of England. The interview schedule was informed by previous literature and co-produced with a peer worker with lived experience of drug recovery treatment. Transcripts were analysed thematically by the research team.

Results

Four major themes were identified from the interviews: A change of focus; challenges; wrap-around support; and target groups.

Discussion

Our findings support existing evidence around the individual benefits to service-users such as changes to lifestyle and reduction of stigma, as well as challenges such as the need for wrap-around support and accessible information. We found that commissioning considerations such as geographical inequalities and the need for multi-service collaboration are important in this setting.

Conclusions

LAIB treatment works well for many people in a community context that offers significant wrap-around support to service-users. The novelty of this research lies in bringing together the views of practitioners and stakeholders as well as treatment/service beneficiaries in evaluating the introduction of LAIB in a community service.

Schlagwörter

Stichwörter der Autor:innen

Harm reductionLong acting injectable buprenorphineOpioid agonist therapyQualitativeRecovery

Autor:innen und Institutionen

  • Division of Health Research, Lancaster University, UK.
  • Lancaster Medical School, Lancaster University, UK.

Zitieren

APA

Fish, R., Mateus, C., Maiden, H., Lawson, E., & Limmer, M. (2025). Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders. Drug and Alcohol Dependence Reports, 15, 100328. https://doi.org/10.1016/j.dadr.2025.100328

Vancouver

Fish R, Mateus C, Maiden H, Lawson E, Limmer M. Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders. Drug and Alcohol Dependence Reports. 2025;15:100328. doi:10.1016/j.dadr.2025.100328

BibTeX
@article{Fish2025,
  author = {Fish, Rebecca and Mateus, Céu and Maiden, Hannah and Lawson, Euan and Limmer, Mark},
  title = {Long acting injectable buprenorphine: Perspectives from service-users, staff and stakeholders},
  journal = {Drug and Alcohol Dependence Reports},
  year = {2025},
  volume = {15},
  pages = {100328},
  doi = {10.1016/j.dadr.2025.100328}
}
Kostenlos starten →